Clinical Trial Update: Study to Investigate the Safety, Tolerability, Absorption, Distribution, Metabolism, and Elimination of RWJ-445380 Administered to Patients With Plaque Psoriasis [Phase 2]

View source ↗

Summary

This document describes a Phase 2 clinical trial evaluating RWJ-445380 for plaque psoriasis, and notes that the study has completed. The focus is on safety, tol…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• RWJ-445380

Snippet

Sponsor: Alza Corporation, DE, USA | Conditions: Chronic Small Plaque Psoriasis | Phase 2 | Status: COMPLETED